|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 1 (January 1), 2000:
pp. 30-38
Increased chemokine receptor CCR7/EBI1 expression enhances the
infiltration of lymphoid organs by adult T-cell leukemia cells
Hitoshi Hasegawa,
Tetsuhiko Nomura,
Masashi Kohno,
Norihiko Tateishi,
Yoji Suzuki,
Nobuji Maeda,
Ryuichi Fujisawa,
Osamu Yoshie, and
Shigeru Fujita
From the First Department of Internal Medicine, Ehime University
School of Medicine, Shigenobu, Ehime 791-0295, Japan; the Department of
Physiology, Ehime University School of Medicine, Shigenobu, Ehime
791-0295, Japan; and the Department of Bacteriology, Kinki University
School of Medicine, Osaka-Sayama, Osaka 589-8511, Japan.
Adult T-cell leukemia (ATL) is characterized by infiltration of
various tissues by circulating ATL cells, a finding often associated
with a poor prognosis. Leukocyte migration from the circulation into
tissues depends on integrin-mediated adhesion to the endothelium, and
integrins are tightly regulated by several factors, such as chemokines.
In this study, we focused on the interaction between chemokines and
chemokine receptors on ATL cells to understand factors involved in ATL
cell infiltration of lymphoid organs. We compared freshly isolated ATL
cells from patients with and without lymphoid organ involvement for the
expression of the chemokine receptor CCR7/EBI1, the functional
receptor for secondary lymphoid-tissue chemokine
(SLC), which is expressed at high levels by high endothelial venules of
lymph nodes and Peyer's patches. Reverse transcriptase-polymerase
chain reaction and flow cytometric analysis, using anti-CCR7 monoclonal
antibody (CCR7.6B3), revealed that ATL cells from patients with
lymphoid organ involvement expressed significantly more CCR7/EBI1 than control CD4+CD45RO+ T cells and ATL cells
from patients without lymphoid organ involvement. Consequently,
significantly more ATL cells from patients with lymphoid organ
involvement than control
CD4+CD45RO+ T cells and ATL cells from
patients without lymphoid organ involvement adhered to
surfaces coated with ICAM-1 and SLC or EBI1-ligand chemokine (ELC), another ligand for CCR7/EBI1, under static and flow
conditions and migrated toward SLC or ELC at a low concentration (30 ng/ml). These findings suggest that increased CCR7/EBI1 expression plays a role in lymphoid organ infiltration of ATL cells. (Blood. 2000;
30-38)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Kawaguchi, Y. Orba, T. Kimura, H. Iha, M. Ogata, T. Tsuji, A. Ainai, T. Sata, T. Okamoto, W. W. Hall, et al.
Inhibition of the SDF-1{alpha}-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice
Blood,
October 1, 2009;
114(14):
2961 - 2968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-R. Pan, H.-C. Chang, Y.-C. Wu, C.-C. Huang, and W.-C. Hung
Tubocapsanolide A Inhibits Transforming Growth Factor-{beta}-activating Kinase 1 to Suppress NF-{kappa}B-induced CCR7
J. Biol. Chem.,
January 30, 2009;
284(5):
2746 - 2754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Byers, P. A. Calloway, L. Shannon, H. D. Cunningham, S. Smith, F. Li, B. C. Fassold, and C. M. Vines
Arrestin 3 Mediates Endocytosis of CCR7 following Ligation of CCL19 but Not CCL21
J. Immunol.,
October 1, 2008;
181(7):
4723 - 4732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Alfonso-Perez, S. Lopez-Giral, N. E. Quintana, J. Loscertales, P. Martin-Jimenez, and C. Munoz
Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia
J. Leukoc. Biol.,
June 1, 2006;
79(6):
1157 - 1165.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ohmori, F. Fukui, M. Kiso, T. Imai, O. Yoshie, H. Hasegawa, K. Matsushima, and R. Kannagi
Identification of cutaneous lymphocyte-associated antigen as sialyl 6-sulfo Lewis X, a selectin ligand expressed on a subset of skin-homing helper memory T cells
Blood,
April 15, 2006;
107(8):
3197 - 3204.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kwon, L. Ogle, B. Benitez, J. Bohuslav, M. Montano, D. W. Felsher, and W. C. Greene
Lethal Cutaneous Disease in Transgenic Mice Conditionally Expressing Type I Human T Cell Leukemia Virus Tax
J. Biol. Chem.,
October 21, 2005;
280(42):
35713 - 35722.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Shimauchi, S. Imai, R. Hino, and Y. Tokura
Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine by CCR4+ Adult T-Cell Leukemia Cells
Clin. Cancer Res.,
March 15, 2005;
11(6):
2427 - 2435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Okutsu, K. Ishii, K. J. Niu, and R. Nagatomi
Cortisol-induced CXCR4 augmentation mobilizes T lymphocytes after acute physical stress
Am J Physiol Regulatory Integrative Comp Physiol,
March 1, 2005;
288(3):
R591 - R599.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lopez-Giral, N. E. Quintana, M. Cabrerizo, M. Alfonso-Perez, M. Sala-Valdes, V. G. G. de Soria, J. M. Fernandez-Ranada, E. Fernandez-Ruiz, and C. Munoz
Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination
J. Leukoc. Biol.,
August 1, 2004;
76(2):
462 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang, L. Xi, J. L. Hunt, W. Gooding, T. L. Whiteside, Z. Chen, T. E. Godfrey, and R. L. Ferris
Expression Pattern of Chemokine Receptor 6 (CCR6) and CCR7 in Squamous Cell Carcinoma of the Head and Neck Identifies a Novel Metastatic Phenotype
Cancer Res.,
March 1, 2004;
64(5):
1861 - 1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Struyf, E. Schutyser, M. Gouwy, K. Gijsbers, P. Proost, Y. Benoit, G. Opdenakker, J. Van Damme, and G. Laureys
PARC/CCL18 Is a Plasma CC Chemokine with Increased Levels in Childhood Acute Lymphoblastic Leukemia
Am. J. Pathol.,
November 1, 2003;
163(5):
2065 - 2075.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al.
Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia
Cancer Res.,
October 1, 2003;
63(19):
6469 - 6477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ding, Y. Shimada, M. Maeda, A. Kawabe, J. Kaganoi, I. Komoto, Y. Hashimoto, M. Miyake, H. Hashida, and M. Imamura
Association of CC Chemokine Receptor 7 with Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma
Clin. Cancer Res.,
August 1, 2003;
9(9):
3406 - 3412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kim, A. Trubetskoy, T. Suzuki, N. A. Jenkins, N. G. Copeland, and J. Lenz
Genome-Based Identification of Cancer Genes by Proviral Tagging in Mouse Retrovirus-Induced T-Cell Lymphomas
J. Virol.,
February 1, 2003;
77(3):
2056 - 2062.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Imaizumi, H. Murota, S. Kanda, Y. Hishikawa, T. Koji, T. Taguchi, Y. Tanaka, Y. Yamada, S. Ikeda, T. Kohno, et al.
Expression of the c-Met Proto-Oncogene and Its Possible Involvement in Liver Invasion in Adult T-cell Leukemia
Clin. Cancer Res.,
January 1, 2003;
9(1):
181 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sasaki, H. Hasegawa, M. Kohno, A. Inoue, M. R. Ito, and S. Fujita
Antagonist of Secondary Lymphoid-Tissue Chemokine (CCR Ligand 21) Prevents the Development of Chronic Graft-Versus-Host Disease in Mice
J. Immunol.,
January 1, 2003;
170(1):
588 - 596.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hinz, P. Lemke, I. Anagnostopoulos, C. Hacker, D. Krappmann, S. Mathas, B. Dorken, M. Zenke, H. Stein, and C. Scheidereit
Nuclear Factor {kappa}B-dependent Gene Expression Profiling of Hodgkin's Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity
J. Exp. Med.,
September 2, 2002;
196(5):
605 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Muller, U. E. Hopken, H. Stein, and M. Lipp
Systemic immunoregulatory and pathogenic functions of homeostatic chemokine receptors
J. Leukoc. Biol.,
July 1, 2002;
72(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nishimura, H. Umehara, T. Nakayama, O. Yoneda, K. Hieshima, M. Kakizaki, N. Dohmae, O. Yoshie, and T. Imai
Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 Expression
J. Immunol.,
June 15, 2002;
168(12):
6173 - 6180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Yoshie, R. Fujisawa, T. Nakayama, H. Harasawa, H. Tago, D. Izawa, K. Hieshima, Y. Tatsumi, K. Matsushima, H. Hasegawa, et al.
Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells
Blood,
March 1, 2002;
99(5):
1505 - 1511.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. E. Hopken, H.-D. Foss, D. Meyer, M. Hinz, K. Leder, H. Stein, and M. Lipp
Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs
Blood,
February 15, 2002;
99(4):
1109 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. E. Wiley, E. B. Gonzalez, W. Maki, M.-t. Wu, and S. T. Hwang
Expression of CC Chemokine Receptor-7 and Regional Lymph Node Metastasis of B16 Murine Melanoma
J Natl Cancer Inst,
November 7, 2001;
93(21):
1638 - 1643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Taylor Jr., K. C. Kimbrell, R. Scoggins, M. Delaney, L. Wu, and D. Camerini
Expression and Function of Chemokine Receptors on Human Thymocytes: Implications for Infection by Human Immunodeficiency Virus Type 1
J. Virol.,
September 15, 2001;
75(18):
8752 - 8760.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Hislop, N. H. Gudgeon, M. F. C. Callan, C. Fazou, H. Hasegawa, M. Salmon, and A. B. Rickinson
EBV-Specific CD8+ T Cell Memory: Relationships Between Epitope Specificity, Cell Phenotype, and Immediate Effector Function
J. Immunol.,
August 15, 2001;
167(4):
2019 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hanon, P. Goon, G. P. Taylor, H. Hasegawa, Y. Tanaka, J. N. Weber, and C. R. M. Bangham
High production of interferon {gamma} but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells
Blood,
August 1, 2001;
98(3):
721 - 726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hjelmström
Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines
J. Leukoc. Biol.,
March 1, 2001;
69(3):
331 - 339.
[Abstract]
[Full Text]
|
 |
|
|
|